Company Filing History:
Years Active: 2017
Title: Su Liansheng: Innovator in Pharmaceutical Chemistry
Introduction
Su Liansheng is a prominent inventor based in Quincy, MA (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for therapeutic applications. Her work is characterized by a commitment to advancing medical science through her inventions.
Latest Patents
Su Liansheng holds a patent for "Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof." This invention provides compounds of formula (IV) or pharmaceutically acceptable salts thereof, with specific variables defined in the patent. The invention also outlines a method for manufacturing these compounds, their therapeutic uses, combinations with other pharmacologically active agents, and pharmaceutical compositions.
Career Highlights
Su Liansheng is associated with Novartis AG, a leading global healthcare company. Her role at Novartis has allowed her to work on groundbreaking research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Throughout her career, Su has collaborated with notable colleagues, including David Weninger Barnes and Gregory Raymond Bebernitz. These collaborations have further enriched her research and contributed to the success of her projects.
Conclusion
Su Liansheng's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. Her patent and work at Novartis AG highlight her dedication to advancing medical science and improving therapeutic options for patients.